Previous close | 26.39 |
Open | 26.54 |
Bid | 25.88 x 100 |
Ask | 25.98 x 100 |
Day's range | 25.59 - 26.77 |
52-week range | 23.14 - 35.56 |
Volume | |
Avg. volume | 492,657 |
Market cap | 1.221B |
Beta (5Y monthly) | 1.14 |
PE ratio (TTM) | N/A |
EPS (TTM) | -4.00 |
Earnings date | 08 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 48.91 |
FOSTER CITY, Calif., May 07, 2024--Mirum Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference
FOSTER CITY, Calif., May 07, 2024--Mirum Announces Publication of Phase 3 MARCH Data in The Lancet Demonstrating Benefits of LIVMARLI (maralixibat) in patients with PFIC
FOSTER CITY, Calif., May 01, 2024--Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) today announced that it will report first quarter 2024 financial results on May 8, 2024. Mirum will also host a conference call to discuss the first quarter 2024 financial results and recent corporate progress.